View drug registration information details.
Items | Registration information |
ID | 513 |
No | 513 |
Brand Name | GAVISCON SUSPENSION |
Ingredients | SODIUM ALGINATE 500 MG, SODIUM BICARBONATE 267 MG, CALCIUM CARBONATE 160 MG |
Dosage Form | SUSPENSION |
Primary Packaging | SACHET |
Storage | DO NOT STORE ABOVE 30C |
Shelf Life | 2 YEARS |
Pack Size | BOX OF 12 SACHETS X 10ML |
Dispensing Category | Prescription only |
ATC Classification | A02BX |
Pharmaceutical Class | ANTACIDS, ANTIULCERANTS |
Indications | TREATMENT OF SYMPTOMS OF GASTRO-OESOPHAGEAL REFLUX SUCH AS ACID REGURGITATION, HEARTBURN AND INDIGESTION RELATED TO REFLUX, FOR EXAMPLE, FOLLOWING MEALS, OR DURING PREGNANCY, OR IN PATIENTS WITH SYMPTOMS RELATED TO REFLUX OESOPHAGITIS |
Contraindications | HYPERSENSITIVITY TO ACTIVE INGREDIENT, MODERATE OR SEVERE RENAL INSUFFICIENCY |
Side Effects | ANAPHYLACTIC REACTION, ANAPHYLACTOID REACTION, URTICARIA, BROMCHOSPASM |
Unit Price | |
EDL |
No |
Description | AN OFF WHITE SUSPENSION WITH ODOUR AND FLAVOUR OF PEPERMINT |
Note | |
License Owner | DKSH LAOS COMPANY LIMITED |
Manufacturer | RECKITT BENCKISER HEALTHCARE(UK)LIMITED |
Country | UNITED KINGDOM |
Import Registration No | PL00063/0628 |
Import Registration Date | 2011-07-27 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2021-04-02 |
FDD Registration No | 01 I 5373/23 |
FDD Registration Date | 2023-01-23 |
Expiry Date | 2026-01-22 |
Back to drug list
|